Also trades as: 3613.HK (HKSE) · $vol 1M
BJTRF OTC
Beijing Tong Ren Tang Chinese Medicine Company Limited
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -50.1%
5Y: -46.0%
$0.65
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$217M
-468.2% ▼
Capital Expenditures
$43M
-97.4% ▼
5Y CAGR: +81.7%
Free Cash Flow
-$260M
-801.3% ▼
Dividends Paid
$276M
-681.1% ▼
Buybacks
$0
+0.0% ▲
Net Change in Cash
$773M
+709.6% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $70M | $78M | $83M | $69M | $630M |
| Depreciation & Amort. | $10M | $9M | $10M | $11M | $88M |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$54M | $8M | -$42M | -$4M | -$774M |
| Other Non-Cash Items | -$7M | $5M | $21M | -$8M | -$161M |
| Operating Cash Flow | $18M | $100M | $71M | $67M | -$217M |
| — Investing Activities — | |||||
| Capital Expenditures | -$2M | -$3M | -$5M | -$3M | -$43M |
| Acquisitions (Net) | $4K | -$2M | -$401K | $7K | $3M |
| Investment Purchases | $0 | -$30M | $0 | -$144M | $0 |
| Investment Sales | $63M | $0 | $46M | $0 | $171M |
| Other Investing | $0 | $0 | $0 | $0 | $1.2B |
| Investing Cash Flow | $62M | -$35M | $41M | -$147M | $1.4B |
| — Financing Activities — | |||||
| Net Debt Issuance | $1M | $221K | -$7M | -$8M | -$119K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | -$25M | -$26M | -$57M | -$35M | -$276M |
| Other Financing | -$10M | -$10M | -$4M | -$4M | -$79M |
| Financing Cash Flow | -$34M | -$35M | -$68M | -$47M | -$355M |
| Net Change in Cash | $48M | $29M | $42M | -$127M | $773M |
| Cash End of Period | $184M | $213M | $255M | $128M | $1.8B |
| Free Cash Flow | $16M | $97M | $66M | $37M | -$260M |